Polyomavirus BKV, EBV Viral Load, and software upgrades
Numéro de sollicitation BCPSHA_14602
Date de publication
Date et heure de clôture 2024/07/12 17:00 HAE
Description
File # PHSA 14602
NOI Title: Polyomavirus BKV, EBV Viral Load, and software upgrades In accordance with applicable trade agreements PHSA, as agent for the Providence Health Care has chosen not to proceed with a competitive process for the following reason:
• the goods or services can be supplied only by the selected supplier and no alternative or substitute exists for the following reason:
(a) due to an absence of competition for technical reasons
• Roche recently developed new IVD Class 3 assays for BKV and EBV that are now Health Canada approved. Roche is the only vendor to have Health Canada approved Class 3 IVD assays for both EBV and BKV. Also, to ensure compatibility with testing of other viral load markers (HIV, HBV, and CMV) in the same run with no pre-sorting of specimens required.
Vendors who wish to challenge this decision should submit a detailed written objection for the attention of April Lee, Procurement Buyer, by email to april.lee1@phsa.ca before 2:00pm Pacific Time, July 12th 2024. PHSA will review any and all issues received by this date and provide due consideration to each objection.
NOI Title: Polyomavirus BKV, EBV Viral Load, and software upgrades In accordance with applicable trade agreements PHSA, as agent for the Providence Health Care has chosen not to proceed with a competitive process for the following reason:
• the goods or services can be supplied only by the selected supplier and no alternative or substitute exists for the following reason:
(a) due to an absence of competition for technical reasons
• Roche recently developed new IVD Class 3 assays for BKV and EBV that are now Health Canada approved. Roche is the only vendor to have Health Canada approved Class 3 IVD assays for both EBV and BKV. Also, to ensure compatibility with testing of other viral load markers (HIV, HBV, and CMV) in the same run with no pre-sorting of specimens required.
Vendors who wish to challenge this decision should submit a detailed written objection for the attention of April Lee, Procurement Buyer, by email to april.lee1@phsa.ca before 2:00pm Pacific Time, July 12th 2024. PHSA will review any and all issues received by this date and provide due consideration to each objection.
Durée du contrat
Voir la description ci-dessus pour voir tous les détails.
Accords commerciaux
-
Veuillez consulter la description ou les documents de l'appel d'offres
Coordonnées
Organisation contractante
- Organisation
-
Providence Health Care
- Adresse
-
1795 Willingdon AveBurnaby, British Columbia, V5C 6E3Canada
- Autorité contractante
- Boseul Lee
- Adresse courriel
- april.lee1@phsa.ca
- Adresse
-
1795 Willingdon AveBurnaby, British Columbia, V5C 6E3Canada
Détails de l'offre
Les détails complets de cette occasion de marché sont disponibles sur un site tiers
Cliquez sur le bouton ci-dessous pour vous rendre vers ce site Web. Le site tiers pourrait exiger la création d’un compte personnel pour consulter l’occasion de marché ou pour soumissionner. Les informations reliées aux frais encourus pour accéder aux détails complets sont indiqués sous l’onglet Description.